Literature DB >> 22115931

Outcome when adrenaline (epinephrine) was actually given vs. not given - post hoc analysis of a randomized clinical trial.

Theresa M Olasveengen1, Lars Wik, Kjetil Sunde, Petter A Steen.   

Abstract

PURPOSE OF THE STUDY: IV line insertion and drugs did not affect long-term survival in an out-of-hospital cardiac arrest (OHCA) randomized clinical trial (RCT). In a previous large registry study adrenaline was negatively associated with survival from OHCA. The present post hoc analysis on the RCT data compares outcomes for patients actually receiving adrenaline to those not receiving adrenaline.
MATERIALS AND METHODS: Patients from a RCT performed May 2003 to April 2008 were included. Three patients from the original intention-to-treat analysis were excluded due to insufficient documentation of adrenaline administration. Quality of cardiopulmonary resuscitation (CPR) and clinical outcomes were compared.
RESULTS: Clinical characteristics were similar and CPR quality comparable and within guideline recommendations for 367 patients receiving adrenaline and 481 patients not receiving adrenaline. Odds ratio (OR) for being admitted to hospital, being discharged from hospital and surviving with favourable neurological outcome for the adrenaline vs. no-adrenaline group was 2.5 (CI 1.9, 3.4), 0.5 (CI 0.3, 0.8) and 0.4 (CI 0.2, 0.7), respectively. Ventricular fibrillation, response interval, witnessed arrest, gender, age and endotracheal intubation were confounders in multivariate logistic regression analysis. OR for survival for adrenaline vs. no-adrenaline adjusted for confounders was 0.52 (95% CI: 0.29, 0.92).
CONCLUSION: Receiving adrenaline was associated with improved short-term survival, but decreased survival to hospital discharge and survival with favourable neurological outcome after OHCA. This post hoc survival analysis is in contrast to the previous intention-to-treat analysis of the same data, but agrees with previous non-randomized registry data. This shows limitations of non-randomized or non-intention-to-treat analyses. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22115931     DOI: 10.1016/j.resuscitation.2011.11.011

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  31 in total

Review 1.  Novelties in pharmacological management of cardiopulmonary resuscitation.

Authors:  Jason A Bartos; Demetris Yannopoulos
Journal:  Curr Opin Crit Care       Date:  2013-10       Impact factor: 3.687

2.  Cardiac resuscitation: Epinephrine to treat cardiac arrest--a double-edged sword.

Authors:  Hans-Richard Arntz; Jan Breckwoldt
Journal:  Nat Rev Cardiol       Date:  2012-05-15       Impact factor: 32.419

3.  Rethinking the role of epinephrine in cardiac arrest: the PARAMEDIC2 trial.

Authors:  Julianna Jung; Julie Rice; Sharon Bord
Journal:  Ann Transl Med       Date:  2018-12

4.  "Resuscitation time bias"-A unique challenge for observational cardiac arrest research.

Authors:  Lars W Andersen; Anne V Grossestreuer; Michael W Donnino
Journal:  Resuscitation       Date:  2018-02-06       Impact factor: 5.262

5.  Effect of prehospital epinephrine on out-of-hospital cardiac arrest: a report from the national out-of-hospital cardiac arrest data registry in Japan, 2011-2012.

Authors:  Tatsuma Fukuda; Naoko Ohashi-Fukuda; Takehiro Matsubara; Masataka Gunshin; Yutaka Kondo; Naoki Yahagi
Journal:  Eur J Clin Pharmacol       Date:  2016-07-13       Impact factor: 2.953

6.  [Current recommendations for basic/advanced life support : Addressing unanswered questions and future prospects].

Authors:  K Fink; B Schmid; H-J Busch
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-09-27       Impact factor: 0.840

Review 7.  Advances in clinical studies of cardiopulmonary resuscitation.

Authors:  Shou-Quan Chen
Journal:  World J Emerg Med       Date:  2015

8.  Extracorporeal Cardiopulmonary Resuscitation in the Pediatric Cardiac Population: In Search of a Standard of Care.

Authors:  Javier J Lasa; Parag Jain; Tia T Raymond; Charles G Minard; Alexis Topjian; Vinay Nadkarni; Michael Gaies; Melania Bembea; Paul A Checchia; Lara S Shekerdemian; Ravi Thiagarajan
Journal:  Pediatr Crit Care Med       Date:  2018-02       Impact factor: 3.624

9.  Comparison of Shenfu Injection () and epinephrine on catecholamine levels in a porcine model of prolonged cardiac arrest.

Authors:  Da Zhang; Chun-Sheng Li; Zhi-Jun Guo; Wen-Peng Yin; Xiao-Min Hou
Journal:  Chin J Integr Med       Date:  2015-03-06       Impact factor: 1.978

Review 10.  [Catecholamines: pro and contra].

Authors:  R Riessen; O Tschritter; U Janssens; M Haap
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-03-25       Impact factor: 0.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.